Box and whiskers plots of the Consortium lung phenotype for 13 subgroups defined by combination of site and genotyping platform.
Supplementary Figure 2
Histogram for distribution of quality scores from imputation.
(Top) Histogram plot for the distribution of quality scores for SNPs imputed from genotyped SNPs on the 610 platform. The vast majority of imputed SNPs had quality scores near 1, indicating high quality. The other genotyping platforms had similar distributions of quality scores. Only ~50% of these imputed SNPs were used for analysis (8, 520, 458) , as approximately half had minor allele frequencies < 0.005. (Bottom) Corresponding histogram plot for the subset of imputed SNPs that were also genotyped. As expected, those SNPs were imputed with even higher quality.
Supplementary Figure 3
Q-Q plot for the distribution of P values of imputed and genotyped SNPs using a randomeffects model in the meta-analysis of the 13 GWAS1+2 subgroups for all individuals, with sex and principal components as covariates.
The genomic control value is lambda = 0.95, so the distribution of P values is not over-inflated. The genomic control value from the meta-analysis of genotyped SNPs common to all platforms was similar (lambda = 0.94; Q-Q plot not shown).
Plot for the top two principal components from the joint analysis of GWAS1+2 individuals and HapMap3 individuals.
Individuals were judged to have European ancestry if principal components 1 and 2 fell within a mean ± 6SD black rectangle formed using principal components from the HapMap3 European dataset. GEC software (http://statgenpro.psychiatry.hku.hk/gec/) was used to calculate the number of independent tests in each region. (a) The middle plot of this panel shows that after conditioning on the most significant SNP (rs57221529) at chr5p15.3 there are SNPs (near AHRR) that meet a regional Bonferroni significance threshold. (b) The middle plot of this panel shows that after conditioning on the most significant SNP (rs10742326) at chr11p12-p13 that there are SNPs (near/over APIP) that meet a regional Bonferroni significance threshold. (a,b) The bottom plots show that after conditioning on both SNPs (from the top and middle plots), that neither region has any significant association. *Asterisks indicate SNPs of maximum significance between random-and fixed-effects meta-analysis and between all CFTR genotypes and p.Phe508del homozygotes P-values are derived from a meta-analysis using inverse variance-based weighting. eQTL P values from association testing in a linear regression model. a eQTLs and genes with nominal P value < 0.05 in either lung and/or whole blood; data for two other genes (MUC4 and EHF) are also shown, given biological plausibility for role in lung disease. N/A= not available. P values < 0.002 meet Bonferroni criteria (http://statgenpro.psychiatry.hku.hk/gec/) for significance at α = 0.05. b Top-ranked regional eQTL P values (with ‡ r 2 > 0.6 with top-ranked GWAS SNPs from 3A, above). c P values < 10 -5 considered "significant" in the SCAN database, while seeQTL reports Q values for all cisassociations. Variants previously reported in candidate gene studies (as of May/June 2014) as associating with some aspect of pulmonary function in CF patients (Phenotype Tested) are listed here with their rs#, other names of the variants (aliases), the reported p-values, the number of subjects tested to achieve that p-value and the publication reporting the association. The right-hand columns give the metaanalysis P value calculated using inverse variance-based weighting for those variants in this study, both for all subjects enrolled and for p.Phe508del homozygotes. The current study evaluated single nucleotide polymorphism only, so other types of variants, such as insertions or deletions (indels) or variable number of repeats were not tested. a These cohorts are not independent of the current study.
Supplementary

b P value reflects the association of the haplotype to the lung disease.
c P value reflects the association of the first SNP in the previously reported haplotype range to the GWAS1+2 phenotype.
d P value reflects the association of the last SNP in the previously reported haplotype range to the GWAS1+2 phenotype.
